Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H A Messner

Showing results (111-120 of 127) with videos related to

Pageof 13
Sort By:
Bone Marrow Transplantation|March 17, 2015
Risk model incorporating donor IL6 and IFNG genotype and gastrointestinal GVHD can discriminate patients at high risk of steroid refractory acute GVHDN Alam, W Xu, E G Atenafu, et al.
Lancet (London, England)|March 24, 1984
Allogeneic bone-marrow transplantation for chronic myelogenous leukaemiaB Speck, M M Bortin, R Champlin, et al.
Bone Marrow Transplantation|March 4, 2014
Risk stratification of organ-specific GVHD can be improved by single-nucleotide polymorphism-based risk modelsD Kim, H-H Won, S Su, et al.
Bone Marrow Transplantation|November 2, 2004
Long-term follow-up of secondary malignancies in adults after allogeneic bone marrow transplantationW Hasegawa, G R Pond, J T Rifkind, et al.
Bone Marrow Transplantation|June 1, 1997
Quality of life following bone marrow transplantation: a comparison of patient reports with population normsH J Sutherland, G M Fyles, G Adams, et al.
Bone Marrow Transplantation|December 1, 1991
Long-term results of bone marrow transplantation for patients with AML, ALL and CML prepared with single dose total body irradiation of 500 cGy delivered with a high dose rateG M Fyles, H A Messner, G Lockwood, et al.
Hematology (Amsterdam, Netherlands)|June 16, 2001
Acute Myeloblastic Leukemia: Management with High-Dose Cytosine Arabinoside, Daunorubicin and Marrow Transplantation; Malignancy; Current Clinical PracticeJ. E. Curtis, Y. Hao, H. A. Messner, et al.
Cancer|December 26, 2001
Illness intrusiveness among survivors of autologous blood and marrow transplantationA D Schimmer, M E Elliott, S E Abbey, et al.
Blood|August 1, 1989
A possible autocrine role for interleukin-6 in two lymphoma cell linesC Yee, A Biondi, X H Wang, et al.
Bone Marrow Transplantation|January 23, 1999
Clinical and economic analysis of allogeneic peripheral blood progenitor cell transplants: a Canadian perspectiveS Couban, G Dranitsaris, P Andreou, et al.
Pageof 13

Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
Bone Marrow Transplantation|March 17, 2015
Risk model incorporating donor IL6 and IFNG genotype and gastrointestinal GVHD can discriminate patients at high risk of steroid refractory acute GVHDN Alam, W Xu, E G Atenafu, et al.
Lancet (London, England)|March 24, 1984
Allogeneic bone-marrow transplantation for chronic myelogenous leukaemiaB Speck, M M Bortin, R Champlin, et al.
Bone Marrow Transplantation|March 4, 2014
Risk stratification of organ-specific GVHD can be improved by single-nucleotide polymorphism-based risk modelsD Kim, H-H Won, S Su, et al.
Bone Marrow Transplantation|November 2, 2004
Long-term follow-up of secondary malignancies in adults after allogeneic bone marrow transplantationW Hasegawa, G R Pond, J T Rifkind, et al.
Bone Marrow Transplantation|June 1, 1997
Quality of life following bone marrow transplantation: a comparison of patient reports with population normsH J Sutherland, G M Fyles, G Adams, et al.
Bone Marrow Transplantation|December 1, 1991
Long-term results of bone marrow transplantation for patients with AML, ALL and CML prepared with single dose total body irradiation of 500 cGy delivered with a high dose rateG M Fyles, H A Messner, G Lockwood, et al.
Hematology (Amsterdam, Netherlands)|June 16, 2001
Acute Myeloblastic Leukemia: Management with High-Dose Cytosine Arabinoside, Daunorubicin and Marrow Transplantation; Malignancy; Current Clinical PracticeJ. E. Curtis, Y. Hao, H. A. Messner, et al.
Cancer|December 26, 2001
Illness intrusiveness among survivors of autologous blood and marrow transplantationA D Schimmer, M E Elliott, S E Abbey, et al.
Blood|August 1, 1989
A possible autocrine role for interleukin-6 in two lymphoma cell linesC Yee, A Biondi, X H Wang, et al.
Bone Marrow Transplantation|January 23, 1999
Clinical and economic analysis of allogeneic peripheral blood progenitor cell transplants: a Canadian perspectiveS Couban, G Dranitsaris, P Andreou, et al.
Pageof 13